A total of 1313 ECs from 16 studies were used to evaluate the relationships between CDKN2A methylation and clinicopathological features, including age, gender, smoking behavior, alcohol consumption, tumor location, tumor diameter, differentiation grade, tumor stage, clinical stage, and lymph node metastasis (Table 4). The gene discussed is CDKN2A; the disease is neoplasm.